Cervical Cancer Screening

HPV Can Happen To Anyone & If Not Kept In Check, Could Lead To Cervical Cancer

We’re enrolling women in a Screening HPV & Cervical Cancer Clinical Trials.

The human papillomavirus (HPV) is a group of viruses that can affect your skin and the body’s moist membranes, such as the cervix, anus, mouth, and throat.

For women, HPV Infection Testing is frequently included in Cervical Cancer treatments screening, which examines the cervix for abnormal cells (entrance to the womb). Cervical screening isn’t a cancer test; it’s a check on the health of the cervix’s cells. If the cells on your cervix change, it doesn’t always imply you have Cervical Cancer; but, in certain circumstances, the abnormal cells must be removed to prevent cancer from developing.

Revive Research Institute is conducting a Screening Clinical Research Trial where we study an investigational product that may be able screen your cervix for any abnormalities so that you can keep a check on your cervix and all over health.

Participation Criteria:

  • Females above the age of 25 years
  • Had a colposcopy referral in a routine cervical cancer screening
  • Comply with the study procedures

The purpose of the investigational product is to detect high risk human papillomavirus (HPV), a virus associated with high risk cervical cancer. Join our Cervical Cancer Clinical Trials and let our experienced research staff including Gynecologists, and Nurses take care of you and your cervix health.

Please provide YOUR contact information only.
HPV and Cervical Cancer Screening women's health center

About the HPV & Cervical Cancer Screening Study

We’re conducting a clinical research study on an experimental product that may be able to help detect HPV and cervical cancer. The test is just for research purposes and will not be used to evaluate your condition. This study will involve a total of 20 specimen collecting sites in the United States, and about 1,800 persons will be enrolled.

A minimum of 20 collection sites will recruit about 1,800 women. Each participant will have two cervical cytology specimens taken prior to colposcopy.

The participant must meet all inclusion criteria. If you qualify and decide to participate, you will receive free-of-cost testing/screening at one of our nearest sites. The entire study procedure should not take more than 45 – 60 minutes.
Women over the age of 25 who are having a colposcopy as part of a regular cervical cancer screening will be eligible to take part in the research.

What to except

Revive Research Institute is conducting a Cervical Cancer Clinical Trial to screen women undergoing colposcopy for cervical disease status. When potentially harmful conditions are detected on time, they save lives. You will get a free of cost cervical checkup that may ensure your future wellbeing. There is no cost to participate in the study and you will receive study-related care from expert physicians and health care professionals.

If you are interested in our cervical cancer clinical trial, please fill out the form and our clinical research representative will reach out to you for further details. This study is a single visit study in which you will be asked questions to determine your eligibility. If eligible, you will be asked to sign and date the Informed Consent Form. You will get study-related care and screening free of cost. This study doesn’t require long-term commitment. It will take 45 – 60 minutes of your time.

Length of study

45 – 60 minutes

Number of study visits

01

Location

Michigan

About HPV & Cervical Cancer

Human papillomavirus infection causes cervical cancer. The majority of human papillomavirus (HPV) infections are mild and resolve on their own, but persistent infection with high-risk human papillomavirus (particularly type 16) can lead to cervix, vulva, vaginal, anus, penis, and oropharyngeal cancer.

The annual incidence of new HPV infections in the United States is estimated to be between 1 million and 5.5 million, with a frequency of up to 20 million people. HPV continues to be a major health concern, since infection rates appear to be rising at an alarming rate. A high-risk HPV infection normally causes no symptoms. However, HPV infections can cause cell changes in the cervical tissue that might ultimately lead to cancer.

Frequently Asked Questions (FAQs)

1. How often should I have a cervical cancer screening?

Cervical Cancer Screening recommendations for women are:

  • Women should start cervical cancer screening at the age of 21
  • Women between the ages of 21 to 29 years should have a Pap test every three years
  • Women between the ages of 30 to 65 years have the choice to get a Pap test every three years, a HR-HPV test every five years, or a Pap test and HR-HPV test every five years.

2. Is it safe to get cervical screening done?

Cervical screening is an excellent test for detecting cell alterations that might develop into cervical cancer. The screening test may miss cell alterations or even cancer however that is an uncommon occurrence.
Watch your symptoms closely and get yourself screened
• After intercourse, there is a lot of bleeding.
• Bleeding in the intervals between periods
• Lower back or stomach aches

3. Does colposcopy affect fertility?

Treatments for precancerous cervical lesions appear to have no effect on a woman’s capacity to conceive. Pregnancy rates were comparable amongst women who underwent a biopsy or colposcopy and those who had a surgical treatment technique.

4. How is cervical cancer treated?

There are no known cervical cancer treatments, but HPV vaccines go a long way in preventing cervical cancers. Cervical cancer can be prevented by receiving HPV vaccines that are available for children at the age of 11. However, vaccines cannot treat pre-existing conditions. Surgery, chemotherapy, and radiation therapy are some of the options available for treating cervical cancer.

5. What causes cervical cancer?

One of the major causes of cervical cancer is human papillomavirus. The human papillomavirus (HPV) is a virus that is spread from one person to another during sexual activity. HPV will infect at least half of sexually active adults at some point in their lives, but only a small percentage of women will develop cervical cancer.